Chapter 1 Methodology and Scope
1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Segment Share Calculation
1.5 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Global Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Artificial Intelligence in Drug Discovery Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.2.4 Global Artificial Intelligence in Drug Discovery Market: Pestle Analysis
3.2.5 Global Artificial Intelligence in Drug Discovery Market: Porter’s Analysis
Chapter 4 Global Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis
4.1 Artificial Intelligence in Drug Discovery Market: Application Movement Analysis
4.2 Drug Optimisation and Repurposing
4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2020 - 2032
4.3 Preclinical Testing
4.3.1 Preclinical Testing Market Estimates And Forecasts, 2020 - 2032
4.4 Other Applications
4.4.1 Other Applications Market Estimates And Forecasts, 2020 - 2032
Chapter 5 Global Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis
5.1 Artificial Intelligence in Drug Discovery Market: Therapeutic Area Movement Analysis
5.2 Oncology
5.2.1 Oncology Market Estimates And Forecasts, 2020 - 2032
5.3 Neurodegenerative Diseases
5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2020 - 2032
5.4 Cardiovascular Disease
5.4.1 Cardiovascular Diseases Market Estimates And Forecasts, 2020 - 2032
5.5 Metabolic Diseases
5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2020 - 2032
5.6 Infectious Disease
5.6.1 Infectious Diseases Market Estimates And Forecasts, 2020 - 2032
5.7 Others
5.7.1 Others Market Estimates And Forecasts, 2020 - 2032
Chapter 6 Global Artificial Intelligence in Drug Discovery Market: Component Estimates & Trend Analysis
6.1 Artificial Intelligence in Drug Discovery Market: Component Movement Analysis
6.2 Software
6.2.1 Software Market Estimates And Forecasts, 2020 - 2032
6.3 Hardware
6.3.1 Hardware Market Estimates And Forecasts, 2020 - 2032
6.4 Services
6.4.1 Services Market Estimates And Forecasts, 2020 - 2032
Chapter 7 Global Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis
7.1 Global Artificial Intelligence in Drug Discovery Market Movement Ananlysis, By region
7.2 Global Artificial Intelligence in Drug Discovery Market Share, By region, 2023 & 2032
7.3 North America
7.3.1 North America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.3.2 U.S.
7.3.2.1 U.S. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.3.3 Canada
7.3.3.1 Canada Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.4 Europe
7.4.1 Europe Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.4.2 U.K.
7.4.2.1 U.K. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.4.3 Germany
7.4.3.1 Germany Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.4.4 France
7.4.4.1 France Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.4.5 Spain
7.4.5.1 Spain Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.4.6 Italy
7.4.6.1 Italy Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.4.7 Russia
7.4.7.1 Russia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.5 Asia Pacific
7.5.1 Asia Pacific AI in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.5.2 China
7.5.2.1 China Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.5.3 India
7.5.3.1 India Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.5.4 Japan
7.5.4.1 Japan Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.5.5 Australia
7.5.5.1 Australia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.5.6 Singapore
7.5.6.1 Singapore Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.5.7 South Korea
7.5.7.1 South Korea Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.6 Latin America
7.6.1 Latin America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.6.2 Brazil
7.6.2.1 Brazil Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.6.3 Mexico
7.6.3.1 Mexico Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.6.4 Argentina
7.6.4.1 Argentina Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.7 MEA
7.7.1 MEA Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.7.2 South Africa
7.7.2.1 South Africa Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.7.3 Saudi Arabia
7.6.3.1 Saudi Arabia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
7.7.4 UAE
7.7.4.1 UAE Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2020 - 2032
Chapter 8 Competitive Analysis
8.1 Recent Developments & Impact Analysis, By Key Market Participants
8.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
8.3. Competitive Dashboard & Company Market Position Analysis
8.3.1 Synergy Analysis: Major Deals & Strategic Alliances
8.3.2 List Of Key Emerging Companies /Technology Disruptors/Innovators
Chapter 9 Competitive Landscape
9.1 IBM Watson
9.1.1 Company Overview
9.1.2 Finanacial Performance
9.1.3 Offerings
9.1.4 Strategic Initiatives
9.2 Exscientia
9.2.1 Company Overview
9.2.2 Finanacial Performance
9.2.3 Offerings
9.2.4 Strategic Initiatives
9.3 GNS Healthcare
9.3.1 Company Overview
9.3.2 Finanacial Performance
9.3.3 Offerings
9.3.4 Strategic Initiatives
9.4 Alphabet (DeepMind)
9.4.1 Company Overview
9.4.2 Finanacial Performance
9.4.3 Offerings
9.4.4 Strategic Initiatives
9.5 Benevolent AI
9.5.1 Company Overview
9.5.2 Finanacial Performance
9.5.3 Offerings
9.5.4 Strategic Initiatives
9.6 BioSymetrics
9.6.1 Company Overview
9.6.2 Finanacial Performance
9.6.3 Offerings
9.6.4 Strategic Initiatives
9.7 Euretos.
9.7.1 Company Overview
9.7.2 Finanacial Performance
9.7.3 Offerings
9.7.4 Strategic Initiatives
9.8 Berg Health
9.8.1 Company Overview
9.8.2 Finanacial Performance
9.8.3 Offerings
9.8.4 Strategic Initiatives
9.9 Atomwise
9.9.1 Company Overview
9.9.2 Finanacial Performance
9.9.3 Offerings
9.9.4 Strategic Initiatives
9.10 Insitro
9.10.1 Company Overview
9.10.2 Finanacial Performance
9.10.3 Offerings
9.10.4 Strategic Initiatives
9.11 Cyclica
9.11.1 Company Overview
9.11.2 Finanacial Performance
9.11.3 Offerings
9.11.4 Strategic Initiatives